Literature DB >> 19873449

PURIFICATION AND PROPERTIES OF DESOXYRIBONUCLEASE ISOLATED FROM BEEF PANCREAS.

M McCarty1.   

Abstract

1. A method is described for the isolation and purification of desoxyribonuclease from a 0.25 N sulfuric acid extract of beef pancreas. The activity of the enzyme is measured by a viscosimetric method using sodium desoxyribonucleate from calf thymus as substrate. 2. The enzyme is highly active, a measurable effect being obtained at concentrations of less than 0.01 microgram per cc. In highly dilute solution the enzyme is rapidly inactivated, and the use of a protective agent such as gelatin or peptone is necessary. 3. The purified material contains traces of a proteolytic enzyme, but displays no ribonuclease, lipase, or phosphatase activity. 4. The enzyme requires activation by magnesium or manganese ion, and citrate serves as a potent inhibitor of the magnesium-activated enzyme. 5. Its enzymatic activity is inhibited by the specific antibody present in the serum of rabbits immunized with enzyme protein.

Entities:  

Year:  1946        PMID: 19873449      PMCID: PMC2142737     

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  4 in total

1.  Nucleoproteins of Cell Nuclei.

Authors:  A E Mirsky; A W Pollister
Journal:  Proc Natl Acad Sci U S A       Date:  1942-09       Impact factor: 11.205

2.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

3.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : II. EFFECT OF DESOXYRIBONUCLEASE ON THE BIOLOGICAL ACTIVITY OF THE TRANSFORMING SUBSTANCE.

Authors:  M McCarty; O T Avery
Journal:  J Exp Med       Date:  1946-01-31       Impact factor: 14.307

4.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : III. AN IMPROVED METHOD FOR THE ISOLATION OF THE TRANSFORMING SUBSTANCE AND ITS APPLICATION TO PNEUMOCOCCUS TYPES II, III, AND VI.

Authors:  M McCarty; O T Avery
Journal:  J Exp Med       Date:  1946-01-31       Impact factor: 14.307

  4 in total
  9 in total

1.  [The clinical effects of streptodornase and streptokinase in purulent exudation and their interpretation as the result of simple irritation].

Authors:  K SONNTAG
Journal:  Klin Wochenschr       Date:  1953-05-01

2.  Mutation in the enzymatic equipment of escherichia coli and proteus OX 19 directed by desoxyribonucleic acid isolated from bacteria of the same and of different species.

Authors:  M U DIANZANI
Journal:  Experientia       Date:  1950

3.  [Not Available].

Authors:  R VENDRELY
Journal:  Experientia       Date:  1947-05-15

4.  Chemical specificity of nucleic acids and mechanism of their enzymatic degradation.

Authors:  E CHARGAFF
Journal:  Experientia       Date:  1950-06-15

5.  The kinetics of DNAse inhibition by specific antibodies.

Authors:  S Ezzeddine; U Al-Khalidi
Journal:  Mol Cell Biochem       Date:  1982-09-03       Impact factor: 3.396

Review 6.  Multiple forms of deoxyribonuclease I.

Authors:  T H Liao
Journal:  Mol Cell Biochem       Date:  1981-01-20       Impact factor: 3.396

7.  The career of Maclyn McCarty.

Authors:  Emil C Gotschlich; Vincent A Fischetti
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

8.  TNFα Amplifies DNaseI Expression in Renal Tubular Cells while IL-1β Promotes Nuclear DNaseI Translocation in an Endonuclease-Inactive Form.

Authors:  Dhivya Thiyagarajan; Ole Petter Rekvig; Natalya Seredkina
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

9.  IL-1β Promotes a New Function of DNase I as a Transcription Factor for the Fas Receptor Gene.

Authors:  Dhivya Thiyagarajan; Hege L Pedersen; Natalya Seredkina; Kjersti D Horvei; Lorena Arranz; Ramon Sonneveld; Tom Nijenhuis; Johan van der Vlag; Ole P Rekvig
Journal:  Front Cell Dev Biol       Date:  2018-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.